JAK2 and acquired polycythemia vera: JAK2 V617F iPS cells from two PV patients (hereafter referred to as PV1 and PV2) with monoallelic and biallelic JAK2 V617F mutation, referred to as JAK2 V617Fhet and JAK2 V617Fhom iPS cells, respectively, and without mutation were studied.